Position
BRAIDWELL LP in Xenon Pharmaceuticals Inc.
Back to the book · All holders of XENE
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $17.8M$44.82 → $58.15
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 1.83M | $81.8M | — | — | — | 2.6% |
| Q1 2026 | 1.34M | $77.8M | $58.15 | $17.8M | −$21.8M | 2.6% |